Table 2.
The expression value of 63 interferon (IFN) signature transcripts in each group.
| Name | NC | FDR | ILE | SLE | Name | NC | FDR | ILE | SLE |
|---|---|---|---|---|---|---|---|---|---|
| TOR1B | 128.8 | 118.0 | 149.4 | 156.7 | C1orf29 | 172.8 | 247.7 | 920.0 | 1 691.1 |
| FAM3B | 97.5 | 99.2 | 101.3 | 120.5 | OAS3 | 178.9 | 227.5 | 522.0 | 701.5 |
| USP18 | 113.2 | 112.7 | 148.3 | 211.4 | OAS1 | 196.6 | 233.1 | 337.4 | 555.1 |
| Siglec-1 | 116.7 | 108.8 | 128.1 | 130.0 | GBP5 | 357.6 | 453.3 | 615.0 | 645.4 |
| IFIT5 | 137.9 | 150.3 | 187.0 | 220.9 | IFIT2 | 486.0 | 617.3 | 1328.5 | 1 833.2 |
| IFRG28 | 128.8 | 128.1 | 166.5 | 208.4 | IFIT1 | 209.3 | 319.7 | 859.7 | 1 169.5 |
| PRKR (EIF2AK1) | 117.6 | 123.8 | 162.0 | 174.4 | IL1RN | 518.7 | 598.9 | 754.7 | 990.2 |
| OASL | 121.0 | 135.7 | 157.5 | 174.5 | OAS1 | 274.1 | 315.2 | 551.9 | 916.2 |
| LGALS3BP | 151.3 | 132.6 | 144.5 | 173.7 | OASL | 233.7 | 278.8 | 569.9 | 801.2 |
| IFIH1 (MDA5) | 196.7 | 205.9 | 304.5 | 364.0 | ZBP1 | 421.0 | 449.3 | 689.5 | 1 084.3 |
| C1QB | 132.7 | 150.8 | 206.4 | 206.7 | CEB1 | 262.4 | 397.3 | 934.7 | 1 342.1 |
| GBP1 | 178.4 | 239.4 | 343.3 | 387.2 | BST2 | 427.8 | 407.4 | 483.4 | 645.8 |
| IFI44 | 147.8 | 151.6 | 349.1 | 630.2 | IFI27 | 654.1 | 229.2 | 2200.6 | 7 750.5 |
| GBP2 | 173.4 | 194.4 | 209.4 | 236.0 | EPSTI1 | 359.9 | 510.2 | 1338.7 | 2 048.0 |
| CARD15 | 197.1 | 205.3 | 248.4 | 266.2 | IFI35 | 459.2 | 456.9 | 683.5 | 852.8 |
| SOCS1 | 149.1 | 168.9 | 183.7 | 200.0 | TAP1 | 876.3 | 862.9 | 1273.0 | 1 325.3 |
| XAF1 | 134.0 | 153.4 | 195.5 | 310.4 | SP110 | 850.8 | 918.1 | 1055.7 | 1 281.5 |
| OAS2 | 133.5 | 131.2 | 209.2 | 288.7 | STAT1 | 654.4 | 745.9 | 1032.0 | 1 074.9 |
| ABCA1 | 244.6 | 259.4 | 347.1 | 477.8 | IFIT4 | 439.3 | 491.2 | 980.9 | 1 608.0 |
| PLSCR1 | 226.3 | 257.3 | 484.0 | 594.6 | Cig5 | 565.6 | 763.4 | 1198.1 | 1 802.2 |
| ISG95 | 217.3 | 190.3 | 221.8 | 252.5 | STAT2 | 889.3 | 979.2 | 1276.7 | 1 622.5 |
| RIG-I (DDX58) | 189.1 | 201.6 | 256.4 | 273.0 | MX2 | 696.6 | 620.2 | 918.2 | 1 109.6 |
| LGP2 | 202.4 | 178.1 | 238.8 | 301.7 | IRF7 | 956.1 | 1080.1 | 1752.8 | 2 782.2 |
| GADD45B | 258.2 | 249.9 | 305.0 | 320.9 | SCOTIN | 1315.1 | 1426.6 | 1730.9 | 2 093.2 |
| PARP9 (BAL) | 302.4 | 300.2 | 461.6 | 563.3 | MT2A | 1404.3 | 1841.4 | 2378.6 | 3 276.2 |
| NT5C3 (PN -1) | 355.1 | 365.7 | 444.3 | 491.0 | MX1 | 882.8 | 945.7 | 1871.0 | 3 084.8 |
| STAT1 | 455.3 | 431.7 | 598.9 | 747.3 | ADAR | 1755.6 | 2231.8 | 2941.5 | 3 129.6 |
| TRIM22 | 473.7 | 433.8 | 766.7 | 1002.0 | G1P2 | 778.5 | 957.3 | 2702.9 | 5 773.1 |
| SERPING1 | 171.0 | 191.0 | 289.4 | 351.0 | STAT1 | 1628.1 | 1668.9 | 2367.1 | 2 697.7 |
| NUB1 (NYREN18) | 375.1 | 338.3 | 386.7 | 427.3 | ISG20 | 2756.1 | 2355.2 | 2805.1 | 3 618.0 |
| LY6E | 1061.0 | 997.9 | 2779.7 | 5 108.7 | |||||
| G1P3 | 2399.7 | 2975.0 | 5397.0 | 8 358.2 | |||||
| IFITM1 | 7889.0 | 7262.3 | 9902.1 | 13 047.3 |
NC, non-autoimmune controls; FDR, first-degree relatives of SLE; ILE, incomplete lupus; SLE, systemic lupus erythematosus.